Signals, Powered By EquityPandit
Aurobindo Pharma has signed definitive agreement to acquire from Apotex International Inc, its commercial operations and certain supporting infrastructure in five European countries, for 74 million euros.
The company, as part of the deal, will acquire commercial infrastructure including personnel, products, marketing authorizations and dossier license rights in Poland, the Czech Republic, the Netherlands (including a manufacturing facility in Leiden), Spain and Belgium.
V Muralidharan, Aurobindo SVP of European Operations stated, “The acquisition announced today is in line with our strategy to grow and diversify our business in Europe. Acquiring Apotex’ businesses in these key five countries will allow us to further expand our product offering, including OTC medicines in the Netherlands, and considerably strengthen our position in Eastern Europe.”
